Showing results (2671-2680 of 5,702) with videos related to
Sort By:
Pageof 571
The Oncologist|November 16, 2023
Development of a Prognostic Model for Early Breast Cancer Integrating Neutrophil to Lymphocyte Ratio and Clinical-Pathological CharacteristicsSara Socorro Faria, Diana Giannarelli, Vladmir Claudio Cordeiro de Lima, et al.The Oncologist|October 16, 2023
A Rare Presentation of Aggressive Renal Cell Carcinoma and the Utility of Early Molecular Testing in Rapidly Progressing Malignancies: A Case ReportDaniel E McLoughlin, Nicholas Chevalier, Edwin Choy, et al.The Oncologist|September 16, 2023
Immune-Related Adverse Event Likelihood Score Identifies "Pure" IRAEs Strongly Associated With Outcome in a Phase I-II Trial PopulationLuca Mazzarella, Federica Giugliano, Eleonora Nicolo, et al.The Oncologist|September 20, 2024
Feasibility and tolerability of anlotinib plus PD-1 blockades as rechallenge immunotherapy in previously treated advanced ESCC: a retrospective studyYonggui Hong, Jun Liu, Ping Lu, et al.The Oncologist|September 14, 2024
Early follow-up of outpatients with oral anticancer therapy in the ONCORAL multidisciplinary community-hospital programClaire Lattard, Chloé Herledan, Thibaut Reverdy, et al.The Oncologist|October 14, 2024
Molecular characteristics of advanced colorectal cancer and multi-hit PIK3CA mutationsFaiza Yasin, Ethan Sokol, Neil Vasan, et al.The Oncologist|September 30, 2024
Chronic myelomonocytic leukemia with NPM1 mutation or acute myeloid leukemia?Sandra Castaño-Díez, José Ramón Álamo, Mònica López-Guerra, et al.The Oncologist|October 2, 2024
Exceptional sustained long-term complete response to Tepotinib in a MET-amplified advanced intrahepatic biliary tract cancer failing Durvalumab plus Cisplatin and GemcitabineAndreas Reichinger, Leo Essl, Paul Kerschner, et al.The Oncologist|September 8, 2024
The impact of inter-cycle treatment delays on overall survival in patients with advanced-stage ovarian cancerLuke Steventon, Kenneth K C Man, Shibani Nicum, et al.The Oncologist|June 7, 2023
Exocrine Pancreatic Insufficiency Induced by Immune Checkpoint InhibitorsDeepika Satish, I-Hsin Lin, James Flory, et al.Pageof 571